Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Mitotech

Mitotech
2009 FOUNDED
PRIVATE STATUS
Corporate LATEST DEAL TYPE
$17M LATEST DEAL AMOUNT
2 INVESTORS
Description

Operator of a biotechnology company intended to develop novel drugs for the treatment of predominantly age-related disorders. The company's offerings are mitochondria targeting cardiolipin peroxidation inhibitors developed in several drug formulations covering a variety of therapeutic areas with focus on ophthalmology and neurodegenerative diseases, enabling doctors to pass through the mitochondrial membrane and concentrate inside the mitochondria.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • 42, rue de la Vallee
  • Luxembourg, 2661
  • Luxembourg
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Mitotech’s full profile, request a free trial.

Mitotech Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Corporate 28-Aug-2018 $17M 000.00 Completed Generating Revenue
1. Early Stage VC 24-Feb-2010 000.00 000.00 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Mitotech Competitors (20)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioCryst Pharmaceuticals Corporation Durham, NC 000 000.00 000000 - 000 000.00
000000 Corporation Malvern, PA 00 00.00 000000000000 00.00
000000 00000000000 Formerly VC-backed Malvern, PA 00 00000 00000000 00000
00000000 Venture Capital-Backed Cleveland, OH 00 00000 0000000000 0 00000
000000000 Formerly VC-backed South San Francisco, CA 00000 000.00 00000000000
To view this company’s complete list of competitors, request access »

Mitotech Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Essex Bio-technology Corporation Minority 000 0000 000000 0
Rusnano Venture Capital Minority 000 0000 000000 0

Mitotech Executive Team (4)

Name Title Board
Seat
Contact
Info
Natalia Perekhvatova Chief Education Officer, Chief Financial Officer & Board Member
Anton Petrov Ph.D Chief Operating Officer
Maxim Skulachev Ph.D Chief Scientific Officer
Lawrence Friedhoff Ph.D Chief Clinical Officer